Revive Therapeutics (OTC:RVVTF) said today it inked a collaborative research deal with Sanyal Biotechnology looking to explore the use of cannabinoids as potential treatments for liver diseases. The collaborative deal will initially focus on the use of cannabidiol on a novel autoimmune hepatitis model, using the Diamond model which was designed and developed by Sanyal Biotechnologyspecifically […]
revivetherapeutics
Revive Therapeutics, University of Wisconsin-Madison ink deal for cannabinoid drug delivery tech
Revive Therapeutics (OTC:RVVTF) said today that it inked a research agreement with the University of Wisconsin-Madison to develop a drug delivery technology for cannibinoids. The research program, led by Jess Reed, is slated to evaluate chitosan-tannin composite biomaterial as a delivery mechanism for cannabinoids. Therapeutic biomaterials made from a composite of chitosan and tannin include […]
